End effector target position learning using feedforward with error back-propagation and recurrent neural networks
By J. Zurada. 1994
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Artificial Intelligence for Clinical Trial Design. (2019, background): “The field of biomedicine has also benefited from this surge in AI methods at many levels, from sophisticated natural language processing (NLP) searches of the biomedical literature [55], to cancer sub-phenotyping using DL [56], to predictions of gene targets of microRNAs [57], drug–target interactio”